カテゴリー： IMARC, 世界, 医療/バイオ

神経変性疾患治療の世界市場2023～2028：産業動向、シェア、規模、成長、機会・予測

◆英語タイトル：Neurodegenerative Disease Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
	◆商品コード：IMARC23DCB0292 ◆発行会社（リサーチ会社）：IMARC ◆発行日：2023年11月 ◆ページ数：143 ◆レポート形式：英語 / PDF ◆納品方法：Eメール ◆調査対象地域：グローバル ◆産業分野：医療

◆販売価格オプション（消費税別）

Single User	USD2,999 ⇒換算￥449,850	見積依頼/購入/質問フォーム
Five User	USD3,999 ⇒換算￥599,850	見積依頼/購入/質問フォーム
Enterprisewide	USD4,999 ⇒換算￥749,850	見積依頼/購入/質問フォーム

★IMARCに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

世界の神経変性疾患治療市場規模は2022年に709億ドルに達しました。今後、IMARC Groupは、2022年から2028年にかけて5.4%の成長率（CAGR）を示し、2028年までに972億ドルに達すると予測しています。
神経変性疾患とは、中枢神経系（CNS）または末梢神経系（PNS）のニューロンの構造と機能が進行性に変性する脳疾患群を指す。現在、身体的あるいは精神的症状を軽減し、患者の生活の質を改善するために、いくつかの薬剤が利用可能です。さらに研究者たちは、神経変性疾患を早期に発見・診断し、その進行を予防するための分子診断法、特にバイオマーカーや画像分光法の開発に注力しています。

過度のアルコール摂取に起因する腫瘍や脳卒中の有病率の増加は、高齢者人口の増加と相まって、神経変性疾患の発症リスクを高める主要な要因の一つとなっています。このことは、アルツハイマー病、パーキンソン病、ハンチントン病、筋萎縮性側索硬化症などの神経変性疾患の早期診断のための分子診断技術の必要性をさらに高めています。これとは別に、研究者たちはこれらの疾患の分類を効果的に理解するために、神経病理学的手法と分子生物学的手法を組み合わせています。また、さまざまなタイプの神経変性疾患に対する低侵襲（MI）スクリーニング検査の開発も進められています。さらに，神経変性疾患の危険因子についての認識を高めるために，非政府組織（NGO）とともに，多くの国の行政機関がさまざまな健康教育キャンペーンを支援しています。その他、インフラの改善による医療施設へのアクセスの増加や可処分所得の増加などが、今後数年間の市場の成長を促進すると予想されます。

主な市場セグメンテーション
IMARC Groupは、神経変性疾患治療の世界市場レポートの各サブセグメントにおける主要動向の分析を、2023年から2028年までの世界、地域、国レベルでの予測とともに提供しています。当レポートでは、適応症、薬剤タイプ、投与経路、流通チャネルに基づいて市場を分類しています。

適応症別
多発性硬化症
パーキンソン病
アルツハイマー病
脊髄性筋萎縮症（SMA）
ハンチントン病
その他

薬剤タイプ別
N-メチル-D-アスパラギン酸受容体拮抗薬
選択的セロトニン再取り込み阻害薬
ドパミン阻害薬
その他

投与経路別
経口剤
注射剤
その他

流通チャネル別
病院薬局
小売薬局
その他

地域別内訳
北米
米国
カナダ
アジア太平洋
中国
日本
インド
韓国
オーストラリア
インドネシア
その他
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
スペイン
ロシア
その他
ラテンアメリカ
ブラジル
メキシコ
その他
中東・アフリカ

競争環境：
Biogen、Boehringer Ingelheim International GmbH、F. Hoffmann-La Roche AG、GlaxoSmithKline Plc、Merck & Co. Inc.、Novartis AG、Pfizer Inc.、Sanofi S.A、Teva Pharmaceutical Industries Ltd. and UCB S.A.を含むいくつかの主要な神経変性疾患治療市場企業の詳細な分析を掲載しています。

本レポートで扱う主な質問
神経変性疾患治療の世界市場はこれまでどのように推移してきたか？
COVID-19が世界の神経変性疾患治療市場に与えた影響は？
主要な地域市場は？
適応症に基づく市場の内訳は？
薬剤の種類に基づく市場の内訳は？
投与経路に基づく市場の内訳は？
販売チャネルに基づく市場の内訳は？
業界のバリューチェーンにおける様々な段階とは？
業界の主な推進要因と課題は何か？
世界の神経変性疾患治療市場の構造と主要プレイヤーは？
業界における競争の程度は？

1. 序論
2. 範囲・調査手法
3. エグゼクティブサマリー
4. イントロダクション
5. 世界の神経変性疾患治療市場
6. 神経変性疾患治療の世界市場規模：疾患別
7. 神経変性疾患治療の世界市場規模：治療薬別
8. 神経変性疾患治療の世界市場規模：投与経路別
9. 神経変性疾患治療の世界市場規模：流通チャネル別
10. 神経変性疾患治療の世界市場規模：地域別
11. SWOT分析
12. バリューチェーン分析
13. ファイブフォース分析
14. 価格分析
15. 競争状況

❖ レポートの目次 ❖

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Neurodegenerative Disease Treatment Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Indication
6.1 Multiple Sclerosis
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Parkinson’s Disease
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Alzheimer’s Disease
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Spinal Muscular Atrophy (SMA)
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Huntington’s Disease
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Others
6.6.1 Market Trends
6.6.2 Market Forecast
7 Market Breakup by Drug Type
7.1 N-methyl-D-aspartate Receptor Antagonists
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Selective Serotonin Reuptake Inhibitors
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Dopamine Inhibitors
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Others
7.4.1 Market Trends
7.4.2 Market Forecast
8 Market Breakup by Route of Administration
8.1 Oral
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Injectable
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Others
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Distribution Channel
9.1 Hospital Pharmacies
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Retail Pharmacies
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Others
9.3.1 Market Trends
9.3.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Biogen
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 Boehringer Ingelheim International GmbH
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3 F. Hoffmann-La Roche AG
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.4 GlaxoSmithKline Plc
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 SWOT Analysis
15.3.5 Merck & Co. Inc.
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.5.4 SWOT Analysis
15.3.6 Novartis AG
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 Financials
15.3.6.4 SWOT Analysis
15.3.7 Pfizer Inc.
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8 Sanofi S.A
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.8.4 SWOT Analysis
15.3.9 Teva Pharmaceutical Industries Ltd.
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 UCB S.A
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.10.4 SWOT Analysis

Figure 1: Global: Neurodegenerative Disease Treatment Market: Major Drivers and Challenges
Figure 2: Global: Neurodegenerative Disease Treatment Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Neurodegenerative Disease Treatment Market: Breakup by Indication (in %), 2022
Figure 5: Global: Neurodegenerative Disease Treatment Market: Breakup by Drug Type (in %), 2022
Figure 6: Global: Neurodegenerative Disease Treatment Market: Breakup by Route of Administration (in %), 2022
Figure 7: Global: Neurodegenerative Disease Treatment Market: Breakup by Distribution Channel (in %), 2022
Figure 8: Global: Neurodegenerative Disease Treatment Market: Breakup by Region (in %), 2022
Figure 9: Global: Neurodegenerative Disease Treatment (Multiple Sclerosis) Market: Sales Value (in Million US$), 2017 & 2022
Figure 10: Global: Neurodegenerative Disease Treatment (Multiple Sclerosis) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 11: Global: Neurodegenerative Disease Treatment (Parkinson’s Disease) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: Neurodegenerative Disease Treatment (Parkinson’s Disease) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: Neurodegenerative Disease Treatment (Alzheimer’s Disease) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: Neurodegenerative Disease Treatment (Alzheimer’s Disease) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Global: Neurodegenerative Disease Treatment (Spinal Muscular Atrophy- SMA) Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Global: Neurodegenerative Disease Treatment (Spinal Muscular Atrophy- SMA) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Global: Neurodegenerative Disease Treatment (Huntington’s Disease) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Global: Neurodegenerative Disease Treatment (Huntington’s Disease) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Global: Neurodegenerative Disease Treatment (Others) Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Global: Neurodegenerative Disease Treatment (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: Global: Neurodegenerative Disease Treatment (N-methyl-D-aspartate Receptor Antagonists) Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: Global: Neurodegenerative Disease Treatment (N-methyl-D-aspartate Receptor Antagonists) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: Global: Neurodegenerative Disease Treatment (Selective Serotonin Reuptake Inhibitors) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: Global: Neurodegenerative Disease Treatment (Selective Serotonin Reuptake Inhibitors) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: Global: Neurodegenerative Disease Treatment (Dopamine Inhibitors) Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: Global: Neurodegenerative Disease Treatment (Dopamine Inhibitors) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: Global: Neurodegenerative Disease Treatment (Others) Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: Global: Neurodegenerative Disease Treatment (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: Global: Neurodegenerative Disease Treatment (Oral) Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: Global: Neurodegenerative Disease Treatment (Oral) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: Global: Neurodegenerative Disease Treatment (Injectable) Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: Global: Neurodegenerative Disease Treatment (Injectable) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: Global: Neurodegenerative Disease Treatment (Others) Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: Global: Neurodegenerative Disease Treatment (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: Global: Neurodegenerative Disease Treatment (Hospital Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: Global: Neurodegenerative Disease Treatment (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: Global: Neurodegenerative Disease Treatment (Retail Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: Global: Neurodegenerative Disease Treatment (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: Global: Neurodegenerative Disease Treatment (Others) Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: Global: Neurodegenerative Disease Treatment (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 41: North America: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: North America: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 43: United States: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: United States: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 45: Canada: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 46: Canada: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 47: Asia-Pacific: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 48: Asia-Pacific: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 49: China: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 50: China: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 51: Japan: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 52: Japan: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 53: India: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 54: India: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 55: South Korea: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 56: South Korea: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 57: Australia: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 58: Australia: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 59: Indonesia: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 60: Indonesia: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 61: Others: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 62: Others: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 63: Europe: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 64: Europe: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 65: Germany: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 66: Germany: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 67: France: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 68: France: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 69: United Kingdom: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 70: United Kingdom: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 71: Italy: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 72: Italy: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 73: Spain: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 74: Spain: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 75: Russia: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 76: Russia: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 77: Others: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 78: Others: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 79: Latin America: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 80: Latin America: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 81: Brazil: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 82: Brazil: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 83: Mexico: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 84: Mexico: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 85: Others: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 86: Others: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 87: Middle East and Africa: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 88: Middle East and Africa: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 89: Middle East and Africa: Neurodegenerative Disease Treatment Market: Breakup by Country (in %), 2022
Figure 90: Global: Neurodegenerative Disease Treatment Industry: SWOT Analysis
Figure 91: Global: Neurodegenerative Disease Treatment Industry: Value Chain Analysis
Figure 92: Global: Neurodegenerative Disease Treatment Industry: Porter's Five Forces Analysis

Table 1: Global: Neurodegenerative Disease Treatment Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Neurodegenerative Disease Treatment Market Forecast: Breakup by Indication (in Million US$), 2023-2028
Table 3: Global: Neurodegenerative Disease Treatment Market Forecast: Breakup by Drug Type (in Million US$), 2023-2028
Table 4: Global: Neurodegenerative Disease Treatment Market Forecast: Breakup by Route of Administration (in Million US$), 2023-2028
Table 5: Global: Neurodegenerative Disease Treatment Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
Table 6: Global: Neurodegenerative Disease Treatment Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 7: Global: Neurodegenerative Disease Treatment Market: Competitive Structure
Table 8: Global: Neurodegenerative Disease Treatment Market: Key Players

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 神経変性疾患治療の世界市場2023～2028：産業動向、シェア、規模、成長、機会・予測(Neurodegenerative Disease Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

神経変性疾患治療の世界市場2023～2028：産業動向、シェア、規模、成長、機会・予測

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp